Michael P. Gray
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2023-02-23
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Enliven Therapeutics, Inc. (ELVN) | Chief Financial Officer and Chief Operating Officer | $454,454 | $1,216,404 |
| 2020 | Enliven Therapeutics, Inc. (ELVN) | Chief Financial Officer and Chief Operating Officer | $392,740 | $541,426 |
| 2019 | Enliven Therapeutics, Inc. (ELVN) | Chief Financial Officer and Chief Operating Officer | $281,458 | $1,271,739 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.